Editorial: infliximab trough cut-off for perianal Crohn's disease - another piece of the therapeutic drug monitoring-guided infliximab dosing puzzle

Aliment Pharmacol Ther. 2017 May;45(9):1279-1280. doi: 10.1111/apt.14020.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Crohn Disease*
  • Drug Monitoring
  • Gastrointestinal Agents
  • Humans
  • Infliximab*
  • Rectal Fistula
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Infliximab